首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1736850

全球有源植入式醫療設備市場規模依設備類型、應用、最終用戶、地區、預測：

Global Active Implantable Medical Devices Market Size By Type of Device, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

主動式植入式醫療設備市場規模及預測

2024 年主動式植入式醫療設備市場規模為 235.5 億美元，預計到 2032 年將達到 472.7 億美元，2026 年至 2032 年的複合年成長率為 9.10%。

主動植入式醫療設備的市場促進因素

主動植入式醫療設備市場的市場促進因素可能受到多種因素的影響，其中包括：

慢性病的流行：隨著全球人口老化和生活方式的改變，糖尿病、神經系統疾病和心血管疾病等慢性疾病正變得越來越普遍。植入式心臟復律去顫器 (AIMD) 在管理各種疾病方面發揮關鍵作用。例如，心律調節器、植入式心臟整流去顫器(ICD) 和神經刺激設備。

技術發展：持續的技術發展使得AIMD日益複雜且有效率。這些技術發展提升了AIMD的功能性和可靠性，包括小型化、更長的電池壽命、無線通訊和增強的感測能力。

微創手術日益受到偏好：微創手術技術因其恢復時間更快、併發症風險更低、患者預後改善等特點，越來越受到患者和醫療保健專業人員的歡迎。 AIMD 是這些手術不可或缺的一部分，因為它們專注於患處進行治療。

醫療保健支出不斷成長：由於醫療保健支出不斷成長，尤其是在已開發國家，越來越多的人能夠負擔得起AIMD等新型醫療技術。政府計畫和報銷指南可能會進一步鼓勵AIMD的使用，預計這將進一步推動市場擴張。

應用領域不斷擴展：AIMD 的應用範圍日益擴大，不僅限於神經內科和心臟病學等傳統領域。這種擴展正在創造新的市場機會，包括泌尿系統、整形外科、疼痛管理，甚至肥胖管理等領域的應用。

老年人口不斷成長：隨著世界人口老化，需要頻繁醫療干預的與老齡化相關的健康問題日益普遍。這導致對用於治療肌肉骨骼疾病、老齡化性聽力損失和尿失禁等疾病的AIMD的需求不斷增加。

新興市場：隨著新興國家可支配收入的提高和醫療基礎設施的快速改善，AIMD 市場正在擴大。由於對尖端醫療設備和治療的需求不斷成長，這些地區擁有巨大的成長潛力。

患者對植入解決方案的偏好：相較於處方藥和外部器械等傳統治療方法，患者通常更青睞植入式醫療設備。這種偏好源自於其長期成本效益、生活品質的提升以及便利性。

有源植入式醫療設備的市場限制

有多種因素可能對主動植入式醫療設備市場造成限制和挑戰。這些因素包括：

監管障礙：製造商在遵守嚴格法規方面面臨重大挑戰。獲得美國食品藥物管理局(FDA) 和歐洲 CE 標誌等監管機構的核准可能耗時耗力且成本高昂。

昂貴：由於使用先進材料和技術，植入式醫療設備的生產成本高。這些成本轉嫁給消費者，限制了其可用性和可負擔性，尤其是在低度開發國家和醫療資源匱乏的地區。

併發症與風險：將電子設備插入體內有許多風險，包括感染疾病、設備故障和組織排斥反應。這些風險可能會阻礙患者和醫護人員使用這些設備，尤其是在有替代療法可用的情況下。

保險覆蓋範圍有限：有源植入式醫療設備的保險覆蓋範圍因器械類型、適應症和當地醫療保健法規而異。由於保險覆蓋範圍有限或報銷困難，患者可能難以獲得這些醫療設備，尤其是在選擇性手術方面。

技術挑戰：需要重大的技術進步來提高主動式植入式醫療設備的功能性、安全性和使用壽命。然而，電池壽命、小型化和無線通訊等技術障礙可能會阻礙創造力並限制這些設備的效用。

倫理與隱私問題：醫療設備與互聯互通功能的整合引發了資料安全和病患隱私問題。對於製造商和醫療保健提供者而言，保護個人醫療資訊並遵守資料隱私法至關重要。

認知和採用有限：病患和醫療保健提供者可能尚未充分認知到有源嵌入型醫療設備的潛在益處。需要進行教育和推廣工作，以提高人們對這些醫療設備的認知，並鼓勵其在適當的護理環境中使用。

Growing Prevalence of Chronic Diseases: Chronic diseases including diabetes, neurological problems, and cardiovascular diseases are growing increasingly common as the world's population ages and lifestyles alter. AIMDs play a critical role in the management of various disorders. Examples include pacemakers, implanted cardioverter defibrillators (ICDs), and neurostimulators.

Technological Developments: As a result of continuing technological developments, increasingly complex and efficient AIMDs have been created. These developments, which increase the functionality and dependability of these gadgets, include miniaturisation, longer-lasting batteries, wireless communication, and enhanced sensing capabilities.

Growing Preference for Minimally Invasive Surgery: Because of its shorter recovery periods, decreased risk of complications, and better patient outcomes, minimally invasive surgical methods are becoming more and more popular among patients and healthcare professionals. Because they provide focused therapy at the afflicted spot, AIMDs are essential to these procedures.

Growing Healthcare Expenditure: More people can now afford new medical technology, such as AIMDs, thanks to growing healthcare spending, especially in industrialised nations. Government programmes and reimbursement guidelines may further encourage the use of these devices, which would further propel market expansion.

Growing Application: AIMDs are being used in more and more medical fields outside of the more conventional ones, like neurology and cardiology. New market opportunities are being created by this expansion, which includes applications in urology, orthopaedics, pain treatment, and even obesity management.

Increasingly Ageing Population: Age-related health issues that frequently call for medical intervention are more common as the world's population ages. As a result, the need for AIMDs to treat ailments such musculoskeletal disorders, age-related hearing loss, and urine incontinence is rising.

Developing Markets: The market for AIMDs is growing as a result of emerging nations' growing disposable income and quickly improving healthcare infrastructure. Because there is a growing need for cutting-edge medical equipment and treatments, these areas have considerable potential for growth.

Implantable Solution Preference of Patients: Patients frequently favour implanted medical devices over more conventional forms of care like prescription drugs or external devices. This preference is frequently motivated by things like long-term cost-effectiveness, enhanced quality of life, and convenience.

Global Active Implantable Medical Devices Market Restraints

Several factors can act as restraints or challenges for the Active Implantable Medical Devices Market. These may include:

Regulatory Obstacles: Manufacturers face a great deal of difficulty in adhering to strict regulations. It can take a long time and money to get approvals from regulatory organisations like the FDA (Food and Drug Administration) in the US and the CE Mark in Europe.

Expensive: The production of active implantable medical devices can be costly due to the use of advanced materials and technologies. Customers bear the cost of these expenses, which restricts their accessibility and affordability, especially in underdeveloped nations or areas with tight healthcare resources.

Complications and dangers: Putting electrical devices into the body comes with a number of dangers, including the possibility of infection, device malfunction, and tissue rejection. Patients and healthcare professionals may be discouraged from using these devices due to concerns about these hazards, particularly if there are alternative therapies available.

Limited Coverage by Insurance: Depending on the type of device, the medical indication, and local healthcare regulations, insurance coverage for active implantable medical devices varies. Patients may find it difficult to obtain these devices due to limited coverage or difficulties with reimbursement, especially for elective treatments.

Technological Difficulties: Increasing the functionality, safety, and longevity of active implanted medical devices requires significant technological advancements. Nonetheless, technical obstacles like battery life, compact size, and wireless communication might hinder creativity and restrict the usefulness of these gadgets.

Ethical and Privacy Issues: Data security and patient privacy are issues that are brought up by the integration of medical equipment with connectivity characteristics. For manufacturers and healthcare providers, protecting private health information and making sure data privacy laws are followed are essential.

Limited Awareness and Adoption: Patients and healthcare providers may not be fully aware of the potential advantages of active implanted medical devices. To raise awareness of these devices and encourage their use in suitable therapeutic settings, education and outreach initiatives are required.

Global Active Implantable Medical Devices Market Segmentation Analysis

The Global Active Implantable Medical Devices Market is Segmented on the basis of Type of Device, Application, End-User, and Geography.

Active Implantable Medical Devices Market Segmentation Analysis

Active Implantable Medical Devices Market, By Type of Device

Implantable Cardioverter Defibrillators (ICDs): Devices designed to monitor heart rhythm and deliver electrical shocks to restore normal heart rhythm in patients at risk of sudden cardiac arrest.
Cardiac Pacemakers: Implantable devices that deliver electrical impulses to regulate heart rate and rhythm in patients with bradycardia or other heart rhythm disorders.
Neurostimulators: Implantable devices that deliver electrical stimulation to specific nerves or areas of the brain to manage chronic pain, movement disorders (e.g., Parkinson's disease), epilepsy, and other neurological conditions.
Implantable Drug Infusion Pumps: Devices that deliver medications directly into the body, typically used to manage chronic pain, spasticity, and other conditions requiring continuous drug delivery.
Implantable Hearing Devices: Devices such as cochlear implants and bone-anchored hearing aids (BAHA) that restore hearing function in individuals with severe hearing loss or deafness.
Implantable Cardiovascular Devices: Including implantable heart monitors, left ventricular assist devices (LVADs), and other devices used to monitor and support cardiovascular function in patients with heart failure and other cardiac conditions.
Other Implantable Devices: Such as implantable glucose monitors for diabetes management, implantable drug-eluting stents for coronary artery disease, and implantable orthopedic devices for bone repair and joint replacement.

Active Implantable Medical Devices Market, By Application

Cardiovascular Diseases: Devices used for the management of various cardiovascular conditions including arrhythmias, heart failure, and coronary artery disease.
Neurological Disorders: Devices used to manage chronic pain, movement disorders, epilepsy, and other neurological conditions.
Hearing Loss: Devices used to restore hearing function in individuals with severe hearing loss or deafness.
Diabetes Management: Implantable glucose monitors and insulin pumps used for continuous glucose monitoring and insulin delivery in diabetic patients.
Orthopedics: Implantable orthopedic devices for bone repair, joint replacement, and spinal stabilization.
Others: Including implantable devices for urological disorders, gastrointestinal disorders, and other medical conditions.

Active Implantable Medical Devices Market, By End-User

Hospitals: Including both general hospitals and specialized cardiac centers, neurological centers, and orthopedic centers where implantable medical devices are implanted and managed.
Ambulatory Surgical Centers (ASCs): Facilities that perform outpatient procedures, including implantation of certain types of implantable medical devices.
Clinics and Specialty Centers: Including cardiology clinics, neurology clinics, diabetes clinics, and other specialized healthcare facilities that provide diagnostic and therapeutic services related to implantable devices.
Home Care Settings: Some implantable medical devices, such as insulin pumps and home monitoring devices, may be managed by patients themselves or by caregivers in home care settings.

Active Implantable Medical Devices Market, By Region

North America: A major market for active implantable medical devices, driven by advanced healthcare infrastructure, high healthcare expenditure, and technological innovation.
Europe: Europe has a significant market for active implantable medical devices, with a strong focus on cardiovascular and neurological applications.
Asia-Pacific: Emerging market with growing demand for implantable medical devices, driven by increasing prevalence of chronic diseases and improving healthcare infrastructure.
Latin America, Middle East, and Africa: Growing markets with expanding access to healthcare services and increasing adoption of advanced medical technologies.

Key Players

The "Global Active Implantable Medical Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cochlear Ltd., Zimmer Biomet, LivaNova PLC, Abbott, Straumann AG, Medtronic, Stryker, 3M, Dentsply Sirona, Allergan Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co., Ltd.

1 INTRODUCTION OF GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY TYPE OF DEVICE

5.1 Overview
5.2 Implantable Cardioverter Defibrillators (ICDs)
5.3 Cardiac Pacemakers
5.4 Neurostimulators
5.5 Implantable Drug Infusion Pumps
5.6 Implantable Hearing Devices
5.7 Implantable Cardiovascular Devices
5.8 Other Implantable Devices

6 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY APPLICATION

6.1 Overview
6.2 Cardiovascular Diseases
6.3 Neurological Disorders
6.4 Hearing Loss
6.5 Diabetes Management
6.6 Orthopedics
6.7 Others

7 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Centers (ASCs)
7.4 Clinics and Specialty Centers
7.5 Home Care Settings

8 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Cochlear Ltd.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Zimmer Biomet
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 LivaNova PLC
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Abbott
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Straumann AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Medtronic
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Stryker
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 3M
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Dentsply Sirona
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Allergan Inc
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments